# Rectal Cancer And Pre-operative Induction Therapy Followed by Dedicated Operation. The RAPIDO Trial

> **NCT01558921** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **University Medical Center Groningen** · enrollment: 920 (actual)

## Conditions studied

- Rectal Cancer

## Interventions

- **OTHER:** M1 scheme
- **OTHER:** standard long course chemoradiotherapy

## Key facts

- **NCT ID:** NCT01558921
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2011-06-21
- **Primary completion:** 2020-03-08
- **Final completion:** 2026-12-31
- **Target enrollment:** 920 (ACTUAL)
- **Last updated:** 2026-05-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01558921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01558921, "Rectal Cancer And Pre-operative Induction Therapy Followed by Dedicated Operation. The RAPIDO Trial". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT01558921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
